FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054488 [Registered on: 27/06/2023] Trial Registered Prospectively
Last Modified On: 22/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of dashamool shilajit vati on prostate enlargement 
Scientific Title of Study   A Randomised controlled clinical study to evaluate the efficacy of dashamool shilajit vati in the management of vatashtheela with special refernce to benign prostate hyperplasia 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Devata Panchakshari 
Designation  PhD Scholar 
Affiliation  Ayurved Seva Sangh Ayurved Mahavidyalaya Ganeshwadi, Panchavati Nashik  
Address  OPD no 6 Shalyatantra OPD

Nashik
MAHARASHTRA
422003
India 
Phone  9422308136  
Fax    
Email  drdevata@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vinay Sonambekar 
Designation  Guide ,HOD ,Principal 
Affiliation  Ayurved Seva Sangh Ayurved Mahavidyalaya 
Address  OPD no 6 Shalyatantra OPD

Nashik
MAHARASHTRA
422003
India 
Phone  9822624890  
Fax    
Email  sonambekar.chinmay@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vinay Sonambekar 
Designation  Guide ,HOD ,Principal 
Affiliation  Ayurved Seva Sangh Ayurved Mahavidyalaya 
Address  OPD no 6 Shalyatantra OPD

Nanded
MAHARASHTRA
422003
India 
Phone  9822624890  
Fax    
Email  sonambekar.chinmay@gmail.com  
 
Source of Monetary or Material Support  
Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik 
 
Primary Sponsor  
Name  Ayurved seva sangh Ayurved Mahavidyalaya 
Address  Ganeshwadi, Panchvati,Nashik Dist Nashik -422003 
Type of Sponsor  Other [State Government aided institution] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Devata Panchakshari  Arogyashala Rugnalaya  OPD No 6 Shalyatantra OPD
Nashik
MAHARASHTRA 
9422308136

drdevata@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee ASS Ayurved Mahavidyalaya Nashik  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N40||Benign prostatic hyperplasia. Ayurveda Condition: VATASHTHILA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Dashamool shilajit vati, Reference: Yogratnakar, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -Water), Additional Information: -
2Comparator Arm (Non Ayurveda)-Tamsulosin HydrochlorideTamsulosin Hydrochloride 400 mg 1 HS for 3 months
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  75.00 Year(s)
Gender  Male 
Details  Patients with clinical features of BPH like Increases frequency, Weak urinary flow, Urgency of micturation,Nocturia,Straining during micturation and feeling of incomplete emptying of bladder,having post voiding residual volume upto 200 ml,patients willing to participate in clinical trial 
 
ExclusionCriteria 
Details  diagnosed case of malignancy of prostate, urethral stricture, active UTI, Patients with uncontrolled DM, TB, Malignancy and HBV
Patients with imapaired renal function
other systemic disorders which can interfere with course of the treatment
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in prostate size
Change in urine Frequency, Urgency of micturition, Nocturia, Straining during micturition  
3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in prostate size
Reduction in post voidal residual urine volume 
3 months 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   not yet published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   BPH is one of the most common senile disese in males.Almost each and every male is affected by this disease hampering the quality of life.Hence the whole world is looking for alternative safe and sure treatment.In Ayurvedic samhitas,BPH is clinically similar to Vatashtheela and here its management is discussed.We have decided to search remedial solution for this burning problem which should be safer ,cost effective and easily available.We have taken 2 groups-Group A which is a study  group of 45 patients which will be treated with Dashamool shilajit vati 250 mg 2 bid for 3 months.Group B whichis a control group of 45 patients treated with Tab Tamsulosin Hydrochloride 400 mg 1 at HS for 3 moths.Assessment criteria is as per IPSS -International Prostate Symptoms Scoring.Analysis of data will be done by scientific methods with the help of statistician.All clinical findings are recorded in case record forms CRF. 
Close